We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+1.2%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$261M
AUM Growth
-$41.4M
Cap. Flow
-$12.8M
Cap. Flow %
-4.9%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
ATXS
Astria Therapeutics
ATXS
+$36M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$32.6M
2
OCUL icon
Ocular Therapeutix
OCUL
+$16.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTL
1
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$90.3M 34.56%
3,489,533
– –
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$72.7M 27.85%
1,397,256
-655,887
-32% -$32.6M
OCUL icon
3
Ocular Therapeutix
OCUL
$2.38B
$40.6M 15.56%
1,932,607
-653,000
-25% -$16.2M
ATXS
4
DELISTED
Astria Therapeutics
ATXS
$34.9M 13.36%
+47,628
New +$36M
ASXC
5
DELISTED
Asensus Surgical, Inc.
ASXC
$22.6M 8.67%
580,515
– –

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q2 2015 Portfolio in Review

As of Q2 2015, SV Health Investors held 5 positions worth $261M, down 14% from $303M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors withdrew a net $12.8M in Q2 2015, reducing 2 holdings. Its largest reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $32.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, SV Health Investors opened a new position in Astria Therapeutics worth $34.9M.

  • SV Health Investors's largest Q2 2015 buy was Astria Therapeutics: 47,628 shares worth $34.9M.
  • SV Health Investors's biggest Q2 2015 reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $32.6M.
  • SV Health Investors's ten largest holdings make up 100% of its $261M portfolio in Q2 2015.
  • SV Health Investors opened 1 new position and closed 0 in Q2 2015.
  • SV Health Investors's portfolio value fell 14% quarter-over-quarter to $261M.

Based on SV Health Investors's 13F filing for Q2 2015, filed 12 Aug 2015.